Company: ZVRA
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001628280-25-039967
Chunk: 76

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 1
Chunk 76
---
 of common stock, diluted67,909 65,056 Weighted-average number of shares of common stock outstanding54,781 54,440 Dilutive effect of outstanding stock options (as converted to common stock)1,544 1,622 Weighted-average shares of common stock outstanding, diluted56,325 56,062 Diluted net income per share of common stock$1.21 $1.16 

24

K.    LeasesThe Company has operating and finance leases for office space, laboratory facilities and various laboratory equipment, furniture and office equipment and leasehold improvements. The Company determines if an arrangement is a lease at contract inception. Lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at the commencement date. The Company does not separate lease and non-lease components. Leases with a term of 12 months or less at commencement are not recorded on the unaudited condensed consolidated balance sheets. Lease expense for these arrangements is recognized on a straight-line basis over the lease term. The Company’s leases have remaining lease terms of less than 1 year and up to approximately 3 years, some of which include options to extend the leases for up to 5 years, and some which include options to terminate the leases within 1 year.The components of lease expense were as follows (in thousands): Three months ended June 30,Six months ended June 30,Lease Cost2025202420252024Finance lease cost:Amortization of right-of-use assets$2 $12 $3 $24 Total finance lease cost2 12 3 24 Operating lease cost289 118 407 211 Short-term lease cost48 59 95 118 Variable lease cost26 — 26 13 Less: sublease income(39)(39)(78)(78)Total lease costs$326 $150 $453 $288 Supplemental cash flow information related to leases was as follows (in thousands):Six months ended June 30,20252024Cash paid for amounts included in the measurement of lease liabilities:Operating cash flows from operating leases$465 $263 Operating cash flows from short-term leases95 118 Operating cash flows from variable lease costs26 13 Right-of-use assets obtained in exchange for lease liabilities:Operating leases$1,115 $419 

25

Supplemental balance sheet information related to leases was as